You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

DEMADEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Demadex, and when can generic versions of Demadex launch?

Demadex is a drug marketed by Roche and Mylan Speciality Lp and is included in two NDAs.

The generic ingredient in DEMADEX is torsemide. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the torsemide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Demadex

A generic version of DEMADEX was approved as torsemide by STRIDES PHARMA on May 27th, 2003.

  Try a Trial

Summary for DEMADEX
Drug patent expirations by year for DEMADEX
Drug Prices for DEMADEX

See drug prices for DEMADEX

Recent Clinical Trials for DEMADEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
New York City Health and Hospitals CorporationPhase 4
Sarfez Pharmaceuticals, Inc.Phase 1
Roxane LaboratoriesN/A

See all DEMADEX clinical trials

US Patents and Regulatory Information for DEMADEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-002 Aug 23, 1993 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-001 Aug 23, 1993 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-001 Aug 23, 1993 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DEMADEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-001 Aug 23, 1993 ⤷  Try a Trial ⤷  Try a Trial
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-002 Aug 23, 1993 ⤷  Try a Trial ⤷  Try a Trial
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 ⤷  Try a Trial ⤷  Try a Trial
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 ⤷  Try a Trial ⤷  Try a Trial
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-003 Aug 23, 1993 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for DEMADEX

See the table below for patents covering DEMADEX around the world.

Country Patent Number Title Estimated Expiration
Denmark 162518 ⤷  Try a Trial
Poland 146086 ⤷  Try a Trial
U.S.S.R. 1480766 CПOCOБ ПOЛУЧEHИЯ KPИCTAЛЛИЧECKOГO TOPACEMИДA (METHOD OF PRODUCING CRYSTALLINE THORASEMIDE) ⤷  Try a Trial
Germany 3763010 ⤷  Try a Trial
Netherlands 7504521 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.